NCT02691351View on ClinicalTrials.gov

Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

September 30, 2020

Conditions
Non-Hodgkin T-cell Lymphoma
Interventions
OTHER

Prospective Registry

"Survival and disease status follow-up at 1st primary treatment, 1st salvage treatment and 2nd salvage treatment~1. Regimen~2. Response Evaluation~3. SUSAR(Suspected, Unexpected, Serious, Adverse Reaction) collection"

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02691351 - Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study | Biotech Hunter | Biotech Hunter